Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain.

Clara MazagatosJacobo MendiorozMercedes Belén RumayorVirtudes Gallardo GarcíaVirginia Álvarez RíoAna Delia Cebollada GraciaNoa Batalla RebolloMaría Isabel Barranco BoadaOlaia Pérez-MartínezAna Sofía Lameiras AzevedoNieves López González-CoviellaDaniel CastrillejoAna Fernández IbáñezJaume Giménez DuranCristina Ramírez CórcolesVioleta Ramos MarínLarrauri AmparoSusana Mongenull null

Published in: Influenza and other respiratory viruses (2024)

We estimated 9364-9875 RSV hospitalisations less than expected, corresponding to a 74%-75% reduction.

Keyphrases

respiratory syncytial virus
emergency department
young adults
risk factors
healthcare
acute care
gestational age
adverse drug
electronic health record